T1	CHEM 46 57	Corticoides
#1	AnnotatorNotes T1	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T2	DISO 76 92	Colitis Ulcerosa
#2	AnnotatorNotes T2	C0009324; Ulcerative Colitis; Disease or Syndrome
T3	DISO 691 701	afectación
#3	AnnotatorNotes T3	C0233576; Mannerism; Sign or Symptom
T4	CHEM 162 173	corticoides
#4	AnnotatorNotes T4	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T5	PROC 178 212	tratamiento con corticoides orales
T6	CHEM 194 205	corticoides
#5	AnnotatorNotes T6	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T7	CHEM 232 243	corticoides
#6	AnnotatorNotes T7	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T8	PROC 254 265	monoterapia
#7	AnnotatorNotes T8	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T9	PROC 274 285	tratamiento
#8	AnnotatorNotes T9	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T10	DISO 292 308	colitis ulcerosa
#9	AnnotatorNotes T10	C0009324; Ulcerative Colitis; Disease or Syndrome
T11	PROC 319 362	ensayo clínico multicéntrico y aleatorizado
T12	DISO 386 420	enfermedad intestinal inflamatoria
#10	AnnotatorNotes T12	C0021390; Inflammatory Bowel Diseases; Disease or Syndrome
T13	DISO 447 463	Colitis ulcerosa
#11	AnnotatorNotes T13	C0009324; Ulcerative Colitis; Disease or Syndrome
T14	PROC 516 527	Diagnóstico
#12	AnnotatorNotes T14	C0011900; Diagnosis; Diagnostic Procedure
T15	DISO 531 547	Colitis Ulcerosa
#13	AnnotatorNotes T15	C0009324; Ulcerative Colitis; Disease or Syndrome
T16	DISO 659 669	enfermedad
#14	AnnotatorNotes T16	C0012634; Disease; Disease or Syndrome
T17	ANAT 717 728	margen anal
#15	AnnotatorNotes T17	C0227423; Transition zone of anal mucous membrane; Body Part, Organ, or Organ Component
T18	PROC 799 827	tratamiento de mantenimiento
#16	AnnotatorNotes T18	C0677908; Maintenance therapy; Therapeutic or Preventive Procedure
T19	CHEM 834 839	5-ASA
#17	AnnotatorNotes T19	C0127615; mesalamine; Organic Chemical · Pharmacologic Substance
T20	PROC 953 977	consentimiento informado
#18	AnnotatorNotes T20	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T21	PROC 1063 1074	tratamiento
#19	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	CHEM 1115 1126	metotrexato
#20	AnnotatorNotes T22	C0025677; methotrexate; Organic Chemical · Pharmacologic Substance
T23	CHEM 1131 1149	agentes biológicos
#21	AnnotatorNotes T23	C0005515; Biological Factors; Biologically Active Substance
T24	CHEM 1171 1182	corticoides
#22	AnnotatorNotes T24	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T25	CHEM 1098 1113	calcineurínicos
T26	CHEM 1234 1245	corticoides
#23	AnnotatorNotes T26	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T27	DISO 1274 1293	Infección sistémica
#24	AnnotatorNotes T27	C0243026; Sepsis; Disease or Syndrome
T28	DISO 1324 1336	enfermedades
#25	AnnotatorNotes T28	C0012634; Disease; Disease or Syndrome
T29	PROC 1430 1441	tratamiento
#26	AnnotatorNotes T29	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T30	DISO 1445 1462	Diabetes mellitus
#27	AnnotatorNotes T30	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T31	DISO 1465 1486	hipertensión arterial
#28	AnnotatorNotes T31	C0020538; Hypertensive disease; Disease or Syndrome
T32	DISO 1505 1528	Enfermedad psiquiátrica
#29	AnnotatorNotes T32	C0004936; Mental disorders; Mental or Behavioral Dysfunction
T33	DISO 1546 1556	enfermedad
#30	AnnotatorNotes T33	C0012634; Disease; Disease or Syndrome
T34	PROC 1592 1614	tratamiento esteroideo
T35	DISO 1339 1358	condiciones médicas
#31	AnnotatorNotes T35	C4745084; Medical Condition; Finding
T36	DISO 1723 1743	reacciones alérgicas
#32	AnnotatorNotes T36	C1527304; Allergic Reaction; Pathologic Function
T37	CHEM 1757 1768	corticoides
#33	AnnotatorNotes T37	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T38	ANAT 397 407	intestinal
#34	AnnotatorNotes T38	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T39	PROC 981 1005	Consentimiento Informado
#35	AnnotatorNotes T39	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T40	PROC 1153 1193	Administración de corticoides sistémicos
T41	CHEM 1086 1096	tiopurinas
T42	ANAT 1478 1486	arterial
#36	AnnotatorNotes T42	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T43	CHEM 1604 1614	esteroideo
#37	AnnotatorNotes T43	C0038317; Steroids; Organic Chemical · Pharmacologic Substance
T44	Date 13 17	2016
T45	Route 58 69	Endovenosos
T46	Route 146 158	intravenosos
#38	AnnotatorNotes T46	C1522726; Intravenous Route of Drug Administration; Functional Concept
T47	Route 206 212	orales
#39	AnnotatorNotes T47	C1527415; Oral Route of Drug administration; Functional Concept
T48	Route 244 250	orales
#40	AnnotatorNotes T48	C1527415; Oral Route of Drug administration; Functional Concept
T49	LIVB 614 622	Paciente
#41	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	Age 623 639	mayor de 18 años
T52	Neg_cue 795 798	Sin
T53	Route 840 844	oral
#42	AnnotatorNotes T53	C1527415; Oral Route of Drug administration; Functional Concept
T54	Route 849 855	tópico
#43	AnnotatorNotes T54	C1522168; Topical Route of Drug Administration; Functional Concept
T55	LIVB 862 870	paciente
#44	AnnotatorNotes T55	C0030705; Patients; Patient or Disabled Group
T56	Date 1075 1081	actual
T57	Duration 1197 1216	los últimos 6 meses
T58	Neg_cue 1218 1221	sin
T59	Route 1246 1252	orales
#45	AnnotatorNotes T59	C1527415; Oral Route of Drug administration; Functional Concept
T63	LIVB 1412 1420	paciente
#46	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T66	PHYS 1618 1626	Embarazo
#47	AnnotatorNotes T66	C0032961; Pregnancy; Organism Function
T67	PHYS 1629 1638	lactancia
#48	AnnotatorNotes T67	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T69	PHYS 1653 1662	gestación
#49	AnnotatorNotes T69	C0032961; Pregnancy; Organism Function
T70	PROC 140 158	bolos intravenosos
#50	AnnotatorNotes T70	C1511237; bolus infusion; Therapeutic or Preventive Procedure
T51	PHYS 893 903	comprender
#51	AnnotatorNotes T51	C0162340; Comprehension; Mental Process
A1	Assertion T18 Negated
A2	Assertion T26 Negated
A3	Status T21 History_of
A4	Status T41 History_of
A5	Status T25 History_of
A6	Status T22 History_of
A7	Status T23 History_of
A8	Assertion T34 Contraindicated
A9	Assertion T43 Contraindicated
A10	Status T36 History_of
#52	AnnotatorNotes T45	C1522726; Intravenous Route of Drug Administration; Functional Concept
#53	AnnotatorNotes T11	C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity
#54	AnnotatorNotes T41	C0597573; thiopurines; Pharmacologic Substance 
#55	AnnotatorNotes T25	C0054450; Calcineurin; Amino Acid, Peptide, or Protein · Enzyme 
#56	AnnotatorNotes T34	C0149783; Steroid therapy; Therapeutic or Preventive Procedure 
T60	Quantifier_or_Qualifier 1490 1501	controladas
A11	Assertion T60 Negated
T61	Quantifier_or_Qualifier 1560 1570	controlada
A12	Assertion T61 Negated
T62	Quantifier_or_Qualifier 1312 1322	controlada
A13	Assertion T62 Negated
T64	Neg_cue 1309 1311	no
T65	Neg_cue 1487 1489	no
T68	Neg_cue 1557 1559	no
A14	Assertion T59 Negated
T71	Spec_cue 1370 1376	puedan
T72	CONC 1377 1387	interferir
A15	Assertion T72 Speculated
#57	AnnotatorNotes T72	C0521102; Interferes with; Functional Concept
R1	Speculation Arg1:T71 Arg2:T72	
T73	Observation 1641 1662	voluntad de gestación
#58	AnnotatorNotes T73	C0032992; Pregnancy, Planned; Finding
R2	Before Arg1:T73 Arg2:T69	
T74	Observation 1680 1707	participación en el estudio
#59	AnnotatorNotes T74	C1278516; Patient participation status; Finding (?)
R3	Overlap Arg1:T66 Arg2:T74	
R4	Overlap Arg1:T73 Arg2:T74	
R5	Overlap Arg1:T69 Arg2:T74	
R6	Overlap Arg1:T67 Arg2:T74	
R7	Has_Route_or_Mode Arg1:T1 Arg2:T45	
T75	Quantifier_or_Qualifier 93 101	Moderada
#60	AnnotatorNotes T75	C0205081; Moderate (severity modifier); Qualitative Concept
R8	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T75	
T76	Quantifier_or_Qualifier 309 317	moderada
#61	AnnotatorNotes T76	C0205081; Moderate (severity modifier); Qualitative Concept
R9	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T76	
T77	Observation 468 486	actividad moderada
#62	AnnotatorNotes T77	C3833417; Moderate activity; Finding
R10	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T77	
R11	Location_of Arg1:T38 Arg2:T12	
T78	CONC 554 610	criterios de la European Crohns and Colitis Organisation
R12	Used_for Arg1:T78 Arg2:T14	
R13	Has_Age Arg1:T49 Arg2:T50	
T79	Quantifier_or_Qualifier 670 679	izquierda
#63	AnnotatorNotes T79	C0205091; Left; Spatial Concept
R14	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T79	
T80	Quantifier_or_Qualifier 682 689	extensa
#64	AnnotatorNotes T80	C0231449; Extended; Spatial Concept
R15	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T80	
T81	Result_or_Value 702 728	>25cm desde el margen anal
R16	Has_Result_or_Value Arg1:T3 Arg2:T81	
T82	CONC 754 768	Índice de Mayo
#65	AnnotatorNotes T82	C5420651; Ulcerative Colitis Disease Activity Index; Intellectual Product
R17	Negation Arg1:T52 Arg2:T18	
R18	Has_Route_or_Mode Arg1:T19 Arg2:T53	
R19	Has_Route_or_Mode Arg1:T19 Arg2:T54	
T83	Result_or_Value 781 790	≥ 6 y ≤10
R20	Has_Result_or_Value Arg1:T82 Arg2:T83	
T84	Observation 733 738	Brote
#66	AnnotatorNotes T84	C4053902; Ulcerative Colitis Flare; Disease or Syndrome
T85	Quantifier_or_Qualifier 739 747	moderado
#67	AnnotatorNotes T85	C0205081; Moderate (severity modifier); Qualitative Concept
R21	Has_Quantifier_or_Qualifier Arg1:T84 Arg2:T85	
T86	Observation 880 934	capacidad de comprender los requerimientos del estudio
R22	Experiences Arg1:T55 Arg2:T51	
R24	Overlap Arg1:T51 Arg2:T20	
R25	Overlap Arg1:T21 Arg2:T56	
R26	Used_for Arg1:T41 Arg2:T21	
R27	Used_for Arg1:T25 Arg2:T21	
R28	Used_for Arg1:T22 Arg2:T21	
R29	Used_for Arg1:T23 Arg2:T21	
R30	Used_for Arg1:T24 Arg2:T40	
R31	Overlap Arg1:T40 Arg2:T57	
R32	Negation Arg1:T58 Arg2:T26	
R33	Has_Route_or_Mode Arg1:T26 Arg2:T59	
T87	Quantifier_or_Qualifier 1253 1269	de acción tópica
R34	Has_Quantifier_or_Qualifier Arg1:T26 Arg2:T87	
A16	Assertion T87 Negated
R35	Negation Arg1:T64 Arg2:T62	
R36	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T62	
R37	Negation Arg1:T65 Arg2:T60	
R38	Location_of Arg1:T42 Arg2:T31	
R39	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T60	
R40	Has_Quantifier_or_Qualifier Arg1:T30 Arg2:T60	
T88	Quantifier_or_Qualifier 1294 1299	grave
#68	AnnotatorNotes T88	C1547227; Severe - Severity of Illness Code; Intellectual Product
R41	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T88	
T89	Quantifier_or_Qualifier 1359 1365	graves
#69	AnnotatorNotes T89	C1547227; Severe - Severity of Illness Code; Intellectual Product
R42	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T89	
T90	Quantifier_or_Qualifier 1300 1306	activa
#70	AnnotatorNotes T90	C0679217; Active State; Idea or Concept
R43	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T90	
R44	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T89	
T91	Observation 1395 1420	elegibilidad del paciente
#71	AnnotatorNotes T91	C1302261; Patient eligible for clinical trial; Finding
R48	Experiences Arg1:T63 Arg2:T29	
R49	Experiences Arg1:T63 Arg2:T27	
R50	Experiences Arg1:T63 Arg2:T28	
R51	Experiences Arg1:T63 Arg2:T35	
R52	Negation Arg1:T68 Arg2:T61	
R53	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T61	
R54	Used_for Arg1:T43 Arg2:T34	
R55	Before Arg1:T32 Arg2:T34	
R56	Before Arg1:T33 Arg2:T34	
R57	Causes Arg1:T37 Arg2:T36	
R58	Used_for Arg1:T4 Arg2:T70	
R59	Has_Route_or_Mode Arg1:T4 Arg2:T46	
R60	Combined_with Arg1:T70 Arg2:T5	
R61	Has_Route_or_Mode Arg1:T6 Arg2:T47	
R62	Used_for Arg1:T6 Arg2:T5	
R63	Has_Route_or_Mode Arg1:T7 Arg2:T48	
R64	Used_for Arg1:T7 Arg2:T8	
R65	Used_for Arg1:T7 Arg2:T9	
T92	Route 1183 1193	sistémicos
R23	Has_Route_or_Mode Arg1:T24 Arg2:T92	
#72	AnnotatorNotes T92	C0205373; Systemic; Functional Concept
#73	AnnotatorNotes T56	C0521116; Current (present time); Temporal Concept
#74	AnnotatorNotes T40	C4053960; Systemic Corticosteroid Therapy; Therapeutic or Preventive Procedure
A17	Experiencer T49 Patient
A18	Experiencer T55 Patient
A19	Experiencer T63 Patient
A20	Status T69 Future
